C
Merck & Co., Inc. MRK
$82.81 -$2.34-2.75% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -12.84% 35.69% 18.56% -42.13% 14.55%
Total Depreciation and Amortization 0.57% -5.03% -2.79% 7.50% 16.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -18.67% -83.26% -81.38% 1,779.69% -83.82%
Change in Net Operating Assets 39.14% -100.11% -171.84% 355.14% 70.08%
Cash from Operations 31.72% -27.54% -62.87% 64.82% 82.43%
Capital Expenditure 42.47% -41.73% -19.67% 1.01% 8.13%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 99.94% -- 100.00%
Divestitures -- -- -- -- --
Other Investing Activities 96.23% 68.51% -278.45% 201.80% -220.35%
Cash from Investing 48.22% -2.98% 62.44% -259.68% 22.31%
Total Debt Issued -- -- 100.00% -100.03% --
Total Debt Repaid 100.00% -363.82% -- -- 100.00%
Issuance of Common Stock -36.84% 58.33% 140.00% -93.15% -16.09%
Repurchase of Common Stock -15.55% -138.04% -10.14% -76.89% -105.74%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -1.32% -5.07% 0.10% 1.66% -1.85%
Other Financing Activities -223.33% -42.86% -31.25% 85.45% -182.05%
Cash from Financing 38.21% -91.26% -24.08% -299.42% 143.21%
Foreign Exchange rate Adjustments 139.74% 142.51% -224.83% 458.54% 40.58%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 85.63% -234.74% -141.33% -41.86% 560.58%